168 related articles for article (PubMed ID: 38473784)
21. Inhibitory actions of oxyresveratrol on the PI3K/AKT signaling cascade in cervical cancer cells.
Tan B; Wikan N; Lin S; Thaklaewphan P; Potikanond S; Nimlamool W
Biomed Pharmacother; 2024 Jan; 170():115982. PubMed ID: 38056236
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA FAM83H-AS1 is regulated by human papillomavirus 16 E6 independently of p53 in cervical cancer cells.
Barr JA; Hayes KE; Brownmiller T; Harold AD; Jagannathan R; Lockman PR; Khan S; Martinez I
Sci Rep; 2019 Mar; 9(1):3662. PubMed ID: 30842470
[TBL] [Abstract][Full Text] [Related]
23. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
[TBL] [Abstract][Full Text] [Related]
24. DEPTOR promotes survival of cervical squamous cell carcinoma cells and its silencing induces apoptosis through downregulating PI3K/AKT and by up-regulating p38 MAP kinase.
Srinivas KP; Viji R; Dan VM; Sajitha IS; Prakash R; Rahul PV; Santhoshkumar TR; Lakshmi S; Pillai MR
Oncotarget; 2016 Apr; 7(17):24154-71. PubMed ID: 26992219
[TBL] [Abstract][Full Text] [Related]
25. BMX/Etk promotes cell proliferation and tumorigenicity of cervical cancer cells through PI3K/AKT/mTOR and STAT3 pathways.
Li Y; Cui N; Zheng PS; Yang WT
Oncotarget; 2017 Jul; 8(30):49238-49252. PubMed ID: 28514765
[TBL] [Abstract][Full Text] [Related]
26. High incidence of PI3K pathway gene mutations in South Indian cervical cancers.
Rose MM; Dhamodharan S; Revathidevi S; Chakkarappan SR; Jagadeesan MG; Subbiah S; Nakaoka H; Inoue I; Murugan AK; Munirajan AK
Cancer Genet; 2022 Jun; 264-265():100-108. PubMed ID: 35568000
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus type 16 E6 promotes cervical cancer proliferation by upregulating transketolase enzymatic activity through the activation of protein kinase B.
Hao S; Meng Q; Sun H; Yang X; Liu B; Zhang Y; Zhou H; Xu Z; Wang Y
Mol Carcinog; 2024 Feb; 63(2):339-355. PubMed ID: 37988232
[TBL] [Abstract][Full Text] [Related]
28. Absence of human papillomavirus infection and activation of PI3K-AKT pathway in cervical clear cell carcinoma.
Ueno S; Sudo T; Oka N; Wakahashi S; Yamaguchi S; Fujiwara K; Mikami Y; Nishimura R
Int J Gynecol Cancer; 2013 Jul; 23(6):1084-91. PubMed ID: 23792604
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
[TBL] [Abstract][Full Text] [Related]
30. Repression of Memo1, a Novel Target of Human Papillomavirus Type 16 E7, Increases Cell Proliferation in Cervical Cancer Cells.
Trejo-Cerro O; Massimi P; Broniarczyk J; Myers M; Banks L
J Virol; 2022 Oct; 96(20):e0122922. PubMed ID: 36197110
[TBL] [Abstract][Full Text] [Related]
31. PI3K/AKT/mTOR Signaling Regulates the Virus/Host Cell Crosstalk in HPV-Positive Cervical Cancer Cells.
Bossler F; Hoppe-Seyler K; Hoppe-Seyler F
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31058807
[TBL] [Abstract][Full Text] [Related]
32. Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma.
Yamamoto N; Kinoshita T; Nohata N; Itesako T; Yoshino H; Enokida H; Nakagawa M; Shozu M; Seki N
Int J Oncol; 2013 May; 42(5):1523-32. PubMed ID: 23483249
[TBL] [Abstract][Full Text] [Related]
33. Network modeling suggests HIV infection phenocopies PI3K-AKT pathway mutations to enhance HPV-associated cervical cancer.
Olwal CO; Fabius JM; Zuliani-Alvarez L; Eckhardt M; Kyei GB; Quashie PK; Krogan NJ; Bouhaddou M; Bediako Y
Mol Omics; 2023 Aug; 19(7):538-551. PubMed ID: 37204043
[TBL] [Abstract][Full Text] [Related]
34. Hsa_circ_CSPP1/MiR-361-5p/ITGB1 Regulates Proliferation and Migration of Cervical Cancer (CC) by Modulating the PI3K-Akt Signaling Pathway.
Yang W; Xie T
Reprod Sci; 2020 Jan; 27(1):132-144. PubMed ID: 32046405
[TBL] [Abstract][Full Text] [Related]
35. HPV-induced Nurr1 promotes cancer aggressiveness, self-renewal, and radioresistance via ERK and AKT signaling in cervical cancer.
Wan PK; Leung TH; Siu MK; Mo XT; Tang HW; Chan KK; Cheung AN; Ngan HY
Cancer Lett; 2021 Jan; 497():14-27. PubMed ID: 33010383
[TBL] [Abstract][Full Text] [Related]
36. Molecular regulation of cervical cancer growth and invasion by VEGFa.
Chen B; Zhang C; Dong P; Guo Y; Mu N
Tumour Biol; 2014 Nov; 35(11):11587-93. PubMed ID: 25135429
[TBL] [Abstract][Full Text] [Related]
37. PIK3CA-mediated PI3-kinase signalling is essential for HPV-induced transformation in vitro.
Henken FE; Banerjee NS; Snijders PJ; Meijer CJ; De-Castro Arce J; Rösl F; Broker TR; Chow LT; Steenbergen RD
Mol Cancer; 2011 Jun; 10():71. PubMed ID: 21663621
[TBL] [Abstract][Full Text] [Related]
38. LAMB3 promotes tumour progression through the AKT-FOXO3/4 axis and is transcriptionally regulated by the BRD2/acetylated ELK4 complex in colorectal cancer.
Zhu Z; Song J; Guo Y; Huang Z; Chen X; Dang X; Huang Y; Wang Y; Ou W; Yang Y; Yu W; Liu CY; Cui L
Oncogene; 2020 Jun; 39(24):4666-4680. PubMed ID: 32398865
[TBL] [Abstract][Full Text] [Related]
39. LAMB3 mediates metastatic tumor behavior in papillary thyroid cancer by regulating c-MET/Akt signals.
Jung SN; Lim HS; Liu L; Chang JW; Lim YC; Rha KS; Koo BS
Sci Rep; 2018 Feb; 8(1):2718. PubMed ID: 29426928
[TBL] [Abstract][Full Text] [Related]
40. LncRNA NEAT1 regulates cervical carcinoma proliferation and invasion by targeting AKT/PI3K.
Guo HM; Yang SH; Zhao SZ; Li L; Yan MT; Fan MC
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4090-4097. PubMed ID: 30024596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
